Published in Biochemistry on November 13, 2001
Protein stability promotes evolvability. Proc Natl Acad Sci U S A (2006) 5.73
Structure-guided recombination creates an artificial family of cytochromes P450. PLoS Biol (2006) 1.90
A serine-substituted P450 catalyzes highly efficient carbene transfer to olefins in vivo. Nat Chem Biol (2013) 1.63
Neutral genetic drift can alter promiscuous protein functions, potentially aiding functional evolution. Biol Direct (2007) 1.61
Heme enzyme structure and function. Chem Rev (2014) 1.58
Conformational plasticity and structure/function relationships in cytochromes P450. Antioxid Redox Signal (2010) 1.40
Evolutionary history of a specialized p450 propane monooxygenase. J Mol Biol (2008) 1.40
Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv. J Biol Chem (2008) 1.37
Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling? EMBO Rep (2005) 1.31
Cytochrome P450 flexibility. Proc Natl Acad Sci U S A (2003) 1.27
Theoretical characterization of substrate access/exit channels in the human cytochrome P450 3A4 enzyme: involvement of phenylalanine residues in the gating mechanism. J Phys Chem B (2009) 1.23
The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b(5). Arch Biochem Biophys (2010) 1.16
Crystal structures of cytochrome P450 2B4 in complex with the inhibitor 1-biphenyl-4-methyl-1H-imidazole: ligand-induced structural response through alpha-helical repositioning. Biochemistry (2009) 1.14
Human cytochrome P450 2E1 structures with fatty acid analogs reveal a previously unobserved binding mode. J Biol Chem (2010) 1.11
CYP1B1 mutations in Spanish patients with primary congenital glaucoma: phenotypic and functional variability. Mol Vis (2009) 1.10
Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules. Biochemistry (2012) 1.08
Conformational equilibrium of cytochrome P450 BM-3 complexed with N-palmitoylglycine: a replica exchange molecular dynamics study. J Am Chem Soc (2006) 1.05
Structural complex of sterol 14α-demethylase (CYP51) with 14α-methylenecyclopropyl-Delta7-24, 25-dihydrolanosterol. J Lipid Res (2011) 1.04
Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution. Nat Chem (2011) 1.00
Controlled oxidation of remote sp3 C-H bonds in artemisinin via P450 catalysts with fine-tuned regio- and stereoselectivity. J Am Chem Soc (2012) 0.99
Effect of conformational dynamics on substrate recognition and specificity as probed by the introduction of a de novo disulfide bond into cytochrome P450 2B1. J Biol Chem (2009) 0.98
An economical method for production of (2)H, (13)CH3-threonine for solution NMR studies of large protein complexes: application to the 670 kDa proteasome. PLoS One (2012) 0.97
Microsomal monooxygenase as a multienzyme system: the role of P450-P450 interactions. Expert Opin Drug Metab Toxicol (2011) 0.94
QM/MM Simulation on P450 BM3 Enzyme Catalysis Mechanism. J Chem Theory Comput (2009) 0.91
Plasticity of CYP2B enzymes: structural and solution biophysical methods. Curr Drug Metab (2012) 0.91
How does the reductase help to regulate the catalytic cycle of cytochrome P450 3A4 using the conserved water channel? J Phys Chem B (2010) 0.91
Mechanism-based inactivation of CYP2B1 and its F-helix mutant by two tert-butyl acetylenic compounds: covalent modification of prosthetic heme versus apoprotein. J Pharmacol Exp Ther (2009) 0.90
Allosteric transitions in cytochrome P450eryF explored with pressure-perturbation spectroscopy, lifetime FRET, and a novel fluorescent substrate, Fluorol-7GA. Biochemistry (2008) 0.89
Interactions of cytochrome P450s with their ligands. Arch Biochem Biophys (2010) 0.87
Structural and thermodynamic basis of (+)-α-pinene binding to human cytochrome P450 2B6. J Am Chem Soc (2013) 0.86
Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function. Arch Biochem Biophys (2006) 0.85
Structure-guided directed evolution of highly selective p450-based magnetic resonance imaging sensors for dopamine and serotonin. J Mol Biol (2012) 0.85
Combining substrate dynamics, binding statistics, and energy barriers to rationalize regioselective hydroxylation of octane and lauric acid by CYP102A1 and mutants. Protein Sci (2007) 0.84
Including ligand-induced protein flexibility into protein tunnel prediction. J Comput Chem (2014) 0.84
P450cin active site water: implications for substrate binding and solvent accessibility. Biochemistry (2013) 0.83
The role of cytochrome P450 2B6 and 2B4 substrate access channel residues predicted based on crystal structures of the amlodipine complexes. Arch Biochem Biophys (2014) 0.82
Insights into an efficient light-driven hybrid P450 BM3 enzyme from crystallographic, spectroscopic and biochemical studies. Biochim Biophys Acta (2016) 0.80
Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias. J Biol Chem (2013) 0.79
Coupling Oxygen Consumption with Hydrocarbon Oxidation in Bacterial Multicomponent Monooxygenases. Acc Chem Res (2015) 0.79
Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene omega-hydroxylase CYP4C7. J Biol Inorg Chem (2009) 0.79
The effect of mutation of F87 on the properties of CYP102A1-CYP4C7 chimeras: altered regiospecificity and substrate selectivity. J Biol Inorg Chem (2008) 0.78
Explicit water near the catalytic I helix Thr in the predicted solution structure of CYP2A4. Biophys J (2003) 0.78
Peroxygenase reactions catalyzed by cytochromes P450. J Biol Inorg Chem (2014) 0.78
Ensemble generation and the influence of protein flexibility on geometric tunnel prediction in cytochrome P450 enzymes. PLoS One (2014) 0.78
Chain length-dependent cooperativity in fatty acid binding and oxidation by cytochrome P450BM3 (CYP102A1). Protein Cell (2011) 0.78
Structural and biophysical characterization of human cytochromes P450 2B6 and 2A6 bound to volatile hydrocarbons: analysis and comparison. Mol Pharmacol (2015) 0.77
A single active-site mutation of P450BM-3 dramatically enhances substrate binding and rate of product formation. Biochemistry (2011) 0.77
Altered spin state equilibrium in the T309V mutant of cytochrome P450 2D6: a spectroscopic and computational study. J Biol Inorg Chem (2007) 0.77
Cytochrome P450 102A2 Catalyzes Efficient Oxidation of Sodium Dodecyl Sulphate: A Molecular Tool for Remediation. Enzyme Res (2010) 0.77
Dynamics and flexibility of human aromatase probed by FTIR and time resolved fluorescence spectroscopy. PLoS One (2013) 0.77
An enlarged, adaptable active site in CYP164 family P450 enzymes, the sole P450 in Mycobacterium leprae. Antimicrob Agents Chemother (2011) 0.76
Conformational Mobility in Cytochrome P450 3A4 Explored by Pressure-Perturbation EPR Spectroscopy. Biophys J (2016) 0.76
A redox-mediated Kemp eliminase. Nat Commun (2017) 0.75
How Do Perfluorinated Alkanoic Acids Elicit Cytochrome P450 to Catalyze Methane Hydroxylation? An MD and QM/MM Study. RSC Adv (2013) 0.75
A Simple Combinatorial Codon Mutagenesis Method for Targeted Protein Engineering. ACS Synth Biol (2016) 0.75
Three-dimensional structure of myosin subfragment-1: a molecular motor. Science (1993) 14.90
Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer (1981) 3.90
A protein catalytic framework with an N-terminal nucleophile is capable of self-activation. Nature (1995) 3.30
Unique biochemical events in bacterial sporulation. Annu Rev Microbiol (1970) 3.11
Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science (1993) 3.00
Enzymatic omega-oxidation. I. Electon carriers in fatty acid and hydrocarbon hydroxylation. J Biol Chem (1966) 2.83
Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure (1995) 2.64
Enzymatic omega-oxidation. II. Function of rubredoxin as the electron carrier in omega-hydroxylation. J Biol Chem (1967) 2.62
An exploration of the activity theory of aging: activity types and life satisfaction among in-movers to a retirement community. J Gerontol (1972) 2.49
Convergent and alternative designs in the digital adhesive pads of scincid lizards. Science (1982) 2.34
Structure of a cytochrome P450-redox partner electron-transfer complex. Proc Natl Acad Sci U S A (1999) 2.30
Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule. Proc Natl Acad Sci U S A (1977) 2.16
Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet (1998) 2.07
Expression of differentiated functions in hepatoma cell hybrids: induction of mouse albumin production in rat hepatoma-mouse fibroblast hybrids. Proc Natl Acad Sci U S A (1972) 1.90
Craniosynostosis, midfacial hypoplasia and foot abnormalities: an autosomal dominant phenotype in a large Amish kindred. J Pediatr (1976) 1.77
Crystal structure and refinement of cytochrome P450terp at 2.3 A resolution. J Mol Biol (1994) 1.70
Transmission of experimental rhinovirus colds in volunteer married couples. J Infect Dis (1976) 1.66
Medicaid in the inner city: the case of maternity care in Chicago. Milbank Q (1990) 1.62
Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J Clin Invest (1992) 1.60
Surface protein-CAT reporter fusions demonstrate differential gene expression in the vir regulon of Streptococcus pyogenes. Mol Microbiol (1992) 1.59
How similar are P450s and what can their differences teach us? Arch Biochem Biophys (1999) 1.57
Physician supply and Medicaid participation. The causes of market failure. Med Care (1989) 1.56
Enzymatic omega-oxidation. 3. Purification and properties of rubredoxin, a component of the omega-hydroxylation system of Pseudomonas oleovorans. J Biol Chem (1968) 1.56
A Mr 46,000 human milk fat globule protein that is highly expressed in human breast tumors contains factor VIII-like domains. Cancer Res (1991) 1.50
The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3. J Biol Chem (1996) 1.48
Medicaid and access to child health care in Chicago. J Health Polit Policy Law (1992) 1.45
Lactadherin (formerly BA46), a membrane-associated glycoprotein expressed in human milk and breast carcinomas, promotes Arg-Gly-Asp (RGD)-dependent cell adhesion. DNA Cell Biol (1997) 1.43
Ligand binding to heme proteins. An evaluation of distal effects. J Biol Chem (1983) 1.42
A three-dimensional model of aromatase cytochrome P450. Protein Sci (1995) 1.30
Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase:cytochrome P-450 interaction. J Biol Chem (1976) 1.20
Oxygenated cytochrome P-450 and its possible role in enzymic hydroxylation. Biochem Biophys Res Commun (1971) 1.17
An active site substitution, F87V, converts cytochrome P450 BM-3 into a regio- and stereoselective (14S,15R)-arachidonic acid epoxygenase. J Biol Chem (1997) 1.17
Cytochrome content of two pseudomonads containing mixed-function oxidase systems. J Bacteriol (1970) 1.15
An N-methyl glutamate dehydrogenase from Pseudomonas M.A. Arch Biochem Biophys (1971) 1.14
Medicaid patients' access to office-based obstetricians. J Health Care Poor Underserved (1991) 1.14
Changes in cytochrome content and electron transport patterns in Pseudomonas putida as a function of growth phase. J Bacteriol (1978) 1.13
The nucleotide excision repair protein UvrB, a helicase-like enzyme with a catch. Mutat Res (2000) 1.12
Fatty acid monooxygenation by cytochrome P-450BM-3. J Biol Chem (1990) 1.12
Mechanism of the synergistic end-product regulation of Bacillus subtilis glutamine phosphoribosylpyrophosphate amidotransferase by nucleotides. Biochemistry (1997) 1.10
Structural alignments of P450s and extrapolations to the unknown. Methods Enzymol (1996) 1.10
Structure of rat BCKD kinase: nucleotide-induced domain communication in a mitochondrial protein kinase. Proc Natl Acad Sci U S A (2001) 1.10
Ring 1 chromosome and dwarfism--a possible syndrome. J Pediatr (1967) 1.09
Mechanism of Rab geranylgeranylation: formation of the catalytic ternary complex. Biochemistry (1998) 1.08
Camphor binding by Pseudomonas putida cytochrome P-450. Kinetics and thermodynamics of the reaction. Biochemistry (1972) 1.06
Structure and function of the glutamine phosphoribosylpyrophosphate amidotransferase glutamine site and communication with the phosphoribosylpyrophosphate site. J Biol Chem (1996) 1.06
Probing structural determinants specifying high thermostability in Bacillus licheniformis alpha-amylase. J Mol Biol (2000) 1.05
Purification of bacterial cytochrome P-450. Methods Enzymol (1978) 1.03
Nitration and inactivation of cytochrome P450BM-3 by peroxynitrite. Stopped-flow measurements prove ferryl intermediates. Eur J Biochem (2000) 1.03
Single turnover kinetics of the reaction between oxycytochrome P-450cam and reduced putidaredoxin. J Biol Chem (1988) 1.01
EPR-spectroscopy of reduced oxyferrous-P450cam. FEBS Lett (1991) 1.01
Studies of the oxygen binding site of cytochrome P-450. Nitric oxide as a spin-label probe. J Biol Chem (1978) 1.00
Hyperthermostable mutants of Bacillus licheniformis alpha-amylase: thermodynamic studies and structural interpretation. Protein Eng (1997) 1.00
Cloning and sequence analysis of human breast epithelial antigen BA46 reveals an RGD cell adhesion sequence presented on an epidermal growth factor-like domain. DNA Cell Biol (1996) 0.99
P450s: structural similarities and functional differences. FASEB J (1996) 0.99
Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule. Somatic Cell Genet (1983) 0.98
The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains. Biochemistry (1996) 0.96
Association of cytochromes P450 with their reductases: opposite sign of the electrostatic interactions in P450BM-3 as compared with the microsomal 2B4 system. Biochemistry (2000) 0.94
Functional domains of human aromatase cytochrome P450 characterized by linear alignment and site-directed mutagenesis. Mol Endocrinol (1993) 0.94
NADPH-P-450 reductase: structural and functional comparisons of the eukaryotic and prokaryotic isoforms. Biochimie (1995) 0.94
Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3. Biochemistry (1996) 0.94
Effects of bereavement on indicators of mental health in elderly widows and widowers. J Gerontol (1983) 0.93
Expression, purification, and properties of the flavoprotein domain of cytochrome P-450BM-3. Evidence for the importance of the amino-terminal region for FMN binding. J Biol Chem (1991) 0.92
Discontinuous variability, in the form of a geometric progression, of albumin production in hepatoma and hybrid cells. Proc Natl Acad Sci U S A (1974) 0.92
Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras. J Biol Chem (1994) 0.91
Fatty acid monooxygenation by P450BM-3: product identification and proposed mechanisms for the sequential hydroxylation reactions. Arch Biochem Biophys (1992) 0.91
NADPH-cytochrome c (P-450) reductase. Spectrophotometric and stopped flow kinetic studies on the formation of reduced flavoprotein intermediates. J Biol Chem (1979) 0.90
Failure of naturally acquired rhinovirus infections to produce temporal immunity to heterologous serotypes. Infect Immun (1974) 0.90
Nitric oxide complexes of cytochrome P-450. FEBS Lett (1975) 0.90
The exchange of phospholipids between cultured chick embryo fibroblasts and their growth medium. Exp Cell Res (1969) 0.90
Rapid reactions of peroxynitrite with heme-thiolate proteins as the basis for protection of prostacyclin synthase from inactivation by nitration. Arch Biochem Biophys (2000) 0.90
Dynamics of protein-bound water in the heme domain of P450BM3 studied by high-pressure spectroscopy: comparison with P450cam and P450 2B4. Biochemistry (1999) 0.90
Equilibrium and kinetic studies of the interaction of cytochrome P-450cam and putidaredoxin. J Biol Chem (1982) 0.89
Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide. Am J Clin Oncol (2000) 0.89
Cell hybridization. Methods Enzymol (1974) 0.89
Protective function of human milk: the milk fat globule. Semin Perinatol (1999) 0.89
Intraocular pressure and outflow facility are unchanged following acute and chronic intracameral chondroitinase ABC and hyaluronidase in monkeys. Exp Eye Res (1997) 0.88
Possible higher valence states of cytochrome P-450 during oxidative reactions. Biochem Biophys Res Commun (1974) 0.87
Reconstitution of the fatty acid hydroxylation function of cytochrome P-450BM-3 utilizing its individual recombinant hemo- and flavoprotein domains. J Biol Chem (1992) 0.87
Pre-steady-state kinetics of the activation of rabbit skeletal muscle myosin light chain kinase by Ca2+/calmodulin. J Biol Chem (1992) 0.87
Bacterial cytochromes P450: isolation and identification. Methods Enzymol (1991) 0.87
Crystallization and preliminary x-ray diffraction analysis of P450terp and the hemoprotein domain of P450BM-3, enzymes belonging to two distinct classes of the cytochrome P450 superfamily. Proc Natl Acad Sci U S A (1992) 0.87
Acute effects of H-7 on ciliary epithelium and corneal endothelium in monkey eyes. Curr Eye Res (2001) 0.87
Thr268 in substrate binding and catalysis in P450BM-3. Arch Biochem Biophys (1998) 0.86
Pseudomonas putida cytochrome P-450: characterization of an oxygenated form of the hemoprotein. Arch Biochem Biophys (1972) 0.86
Acute epidural abscess. Am J Emerg Med (1987) 0.86
H-7 increases trabecular facility and facility after ciliary muscle disinsertion in monkeys. Invest Ophthalmol Vis Sci (1999) 0.86
The role of oxygenated cytochrome P-450 and of cytochrome b5 in hepatic microsomal drug oxidations. Drug Metab Dispos (1974) 0.85
Hospital outpatient services and Medicaid patients' access to care. Med Care (1991) 0.85
Modulation of leucine transaminase activity by dietary means. Am J Physiol (1975) 0.85
Single turnover studies with oxy-cytochrome P-450cam. Arch Biochem Biophys (1986) 0.85
Analysis of discontinuous variation in albumin production by hepatoma cells at the cellular level. Somatic Cell Genet (1979) 0.85
The reduction of putidaredoxin reductase by reduced pyridine nucleotides. Arch Biochem Biophys (1988) 0.84
Anti-BA46 monoclonal antibody Mc3: humanization using a novel positional consensus and in vivo and in vitro characterization. Cancer Res (1995) 0.84
Purification and properties of putidaredoxin reductase. J Biol Chem (1983) 0.84
Analysis of variability in albumin content of sister hepatoma cells and a model for geometric phenotypic variability (quantitative shift model). Somat Cell Mol Genet (1984) 0.84
Relationship of active site topology to substrate specificity for cytochrome P450terp (CYP108). J Biol Chem (1994) 0.83
The FMN-binding domain of cytochrome P450BM-3: resolution, reconstitution, and flavin analogue substitution. Biochemistry (2000) 0.83
Cloning and sequencing of a complementary DNA encoding a Mr 70,000 human breast epithelial mucin-associated antigen. Cancer Res (1990) 0.83
The widespread nature of phenotypic variability in hepatomas and cell lines, in the form of a geometric series. J Theor Biol (1983) 0.83